908 Devices Inc Ordinary Shares MASS
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
-
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference
-
908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook
-
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026
Trading Information
- Previous Close Price
- $9.35
- Day Range
- $9.44–9.73
- 52-Week Range
- $5.03–11.25
- Bid/Ask
- $9.01 / $11.50
- Shares Outstanding
- 41.33M
- Market Cap
- $393.50M
- Volume/Avg
- 279,726 / 384,883
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.75
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 172
- Website
- https://www.908devices.com
Valuation
|
Metric
|
MASS
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.86 |
Price/Sales | 5.75 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MASS
|
|---|---|
Quick Ratio | 2.29 |
Current Ratio | 2.67 |
Interest Coverage | — |
Quick Ratio
MASS
Profitability
|
Metric
|
MASS
|
|---|---|
Return on Assets (Normalized) | −3.71% |
Return on Equity (Normalized) | −5.14% |
Return on Invested Capital (Normalized) | −7.77% |
Return on Assets
MASS
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|GCng%W@ | LOCK|&LLnl | $176B | |||
| Medtronic PLC
MDT
| LOCK|&WM^?w% | LOCK|!?YS | $116B | |||
| Stryker Corp
SYK
| LOCK|Rt>><G$ | LOCK|t&S | $106B | |||
| Boston Scientific Corp
BSX
| LOCK|%WrmT?J | LOCK|P?&F | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|?Z%VhRk | LOCK|Tkh<N | $49B | |||
| DexCom Inc
DXCM
| LOCK|^F%B$@^m | LOCK|!HV$$ | $31B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$rXl?% | LOCK|TXh | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|>!k | LOCK|&@f | $24B | |||
| Steris PLC
STE
| LOCK|&&?vjb | LOCK|!twfp | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|F%>?mQs | LOCK|C& | $18B |
United States